Come up with a name for your new list and we'll add to it:
AxioMx raised a round of funding on November 03, 2014. Investors include
Vital Venture Capital.
AxioMx is a provider in recombinant antibody technologies. AxioMx's platform of phage display libraries, Rapid Liquid Screening, and affinity maturation methods enables fast delivery of highly specifi…